[1]贺晓立,王 军,余 静,等.沈力教授治疗乳腺癌十一法*[J].陕西中医,2020,(1):92-94.
 HE Xiaoli,WANG Jun,YU Jing,et al.Professor SHEN Li’s treatment of breast cancer by using eleven TCM methods[J].,2020,(1):92-94.
点击复制

沈力教授治疗乳腺癌十一法*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年1期
页码:
92-94
栏目:
名老中医经验
出版日期:
2020-01-05

文章信息/Info

Title:
Professor SHEN Li’s treatment of breast cancer by using eleven TCM methods
文章编号:
DOI:10.3969/j.issn.10007369.2020.01.026
作者:
贺晓立王 军余 静沈 力
中国科学院大学宁波华美医院中医科(宁波 315010)
Author(s):
HE XiaoliWANG JunYU Jinget al.
Department of TCM,Ningbo Huamei Hospital,University of Chinese Academy of Sciences(Ningbo 315010)
关键词:
沈力乳腺癌临床经验中医药扶正祛邪复发转移
Keywords:
Key words 〖WT5BZ〗〖HT5”SS〗SHEN LiBreast cancerClinical experienceTraditional Chinese medicineStrengthening body resistance to eliminate pathogenic factorsRecurrence and metastasis
分类号:
R737.9
文献标志码:
A
摘要:
摘 要 乳腺癌是我国女性发病率最高的恶性肿瘤,并以每年高于发达国家1~2个百分点的速度快速增长,该病起病隐匿,发现时往往已是晚期,西医综合治疗效果不佳。浙江省名中医沈力教授在多年临证实践中系统总结了乳腺癌防治以及围手术期、放化疗期的综合治疗,取得了较好的临床疗效,本文详细介绍了沈力教授治疗乳腺癌的经验,将其整理归纳,总结为两期十一法,并附以医案,以资各位同道参考借鉴。
Abstract:
Abstract 〖WT5BZ〗〖HT5”SS〗Breast cancer is the most common of malignancy in Chinese women and is growing faster than the developed countries by 12 percent each year.The initial symptoms of this disease is unobvious.It is often terminal when most common diagnosed.But the western medicine is still lack of efficient therapies on treating terminal stage of breast cancer.Professor Shen Li,a famous traditional Chinese medicine doctor in Zhejiang province had practiced many years in treating breast cancer and preventing it from recurrence and metastasis postsurgery or postradiotherapy and chemotherapy and His treatments achieved good clinical efficacy.This paper introduces experiences of professor Shen Li in the treatment of breast cancer,which are gathered and summed up into two stages with eleven methods,and attaches a case report as references for peers.

参考文献/References:

[1] Chen WQ,Zhang SW,Zou XN,et al.Cancer incidence and mortality in China,2006[J].Chinese Journal of Cancer Research,2011,23(1):39.
[2] 〖JP2〗Halsted CP,Benson JR,Jatoi I.A historical account of breast cancer surgery:beware of local recurrence but be not radical.[J].Future Oncology,2014,10(9):16491657.〖JP〗
[3] Montalvo DN,Nicolas Gonzalez M,María T Montalvo V,et al.Patterns of recurrence and survival in breast cancer[J].Oncology Reports,2008,20(3):531535.
[4] Roth BJ,Krilov L,Adams S,et al.Clinical cancer advances 2012:annual report on progress against cancer from the american society of clinical oncology[J].J Clin Oncol,2013,31(1):131161.
[5] 〖JP2〗Desantis C,Ma J,Bryan L,et al.Breast cancer statistics,2013[J].Ca A Cancer Journal for Clinicians,2014,64(1):5262.〖JP〗
[6] 陈建萍,赵淑华,卓灏柘,等.中医防治乳腺癌复发与转移的策略与方法[J].环球中医药,2011,4(2):125128.
[7] 任黎萍,张晓清.归脾汤和龟鹿二仙汤加减治疗乳腺癌化疗后骨髓抑制50例[J].陕西中医,2009,30(7):2829.
[8] 李茂林,孙显峰.益气升白汤治疗乳腺癌化疗后白细胞减少症109例[J].陕西中医,2010,31(2):56.
[9] 余 静.沈力主任医师对肿瘤放化疗不良反应的中医辨证施治[J].浙江中医药大学学报,2005,29(5):3738. 
[10] 余文亚,沈 力.益气养阴解毒汤辅助放化疗治疗鼻咽癌临床观察[J].新中医,2016,48(12):142144.
[11] 湛 丽,谢丰培,傅明杰.乳腺癌组织发生的同源性与形态分化的多向性[J].临床与实验病理学杂志,2004,20(1):9193.
[12] 陈 丽,叶丽红.乳腺癌手术前后的病证分型[J].长春中医药大学学报,2008,24(3):276277.
[13] 〖JP3〗富 琦,王 皓,韩 冬,等.乳腺癌术后患者化疗前后中医证候变化的临床研究[J].北京中医药,2012,31(1):46.〖JP〗
[14] 吴雪雪,杨 毅,时光喜.姜兆俊从肾虚论治乳腺增生病经验[J].实用中医药杂志,2013,29(12):1056.
[15] 王登正,刘佩珍,张洪亮,等.论肿瘤治疗的“屡攻屡补,以平为期”原则[J].新疆中医药,2008,26(5):7475.

相似文献/References:

[1]陈 楠,王光辉△,贺 赛,等.养正合剂改善乳腺癌术后化疗者不适及对患者细胞因子、红细胞免疫的影响[J].陕西中医,2019,(10):1357.
 CHEN Nan,WANG Guanghui,HE Sai,et al.Yangzheng mixture improves the discomfort of postoperative chemotherapy in patients with breast cancer and its immunity to cytokines and red blood cells[J].,2019,(1):1357.
[2]张贺,姜大庆.鸦胆子素D对乳腺癌MDAMB231细胞增殖与凋亡及细胞周期的影响*[J].陕西中医,2019,(11):1495.
 ZHANG He,JIANG Daqing..Effects of Bruceine D on proliferation,apoptosis and cell cycle of breast cancer MDAMB231 cells[J].,2019,(1):1495.
[3]张栓宝,张燕平△,严宁娟.康莱特注射液对乳腺癌新辅助化疗患者免疫功能、血管内皮生长因子及生活质量的影响[J].陕西中医,2019,(11):1566.
 ZHANG Shuanbao,ZHANG Yanping,YAN Ningjuan..Effect of Kanglaite injection on immune function,VEGF and quality of life in patients with breast cancer receiving neoadjuvant chemotherapy[J].,2019,(1):1566.
[4]刘歆春,李锁南,黄飞燕.乳岩汤联合西药治疗乳腺癌疗效及对患者免疫功能的影响[J].陕西中医,2021,(9):1201.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.012]
[5]冯秀梅,马 兰,罗玉群,等.益气活血方对乳腺癌MCF-7细胞系增殖侵袭能力及miR-100表达水平影响的研究[J].陕西中医,2021,(11):1527.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.007]
 FENG Xiumei,MA Lan,LUO Yuqun,et al.Yiqi Huoxue recipe to inhibit breast cancer cell proliferation and invasion and increase the expression of miR-100[J].,2021,(1):1527.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.007]
[6]陈 军,孙 嫘,惠建荣,等.艾灸对三阴性乳腺癌移植瘤小鼠生存期的影响及机制研究[J].陕西中医,2022,(7):819.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.001]
 CHEN Jun,SUN Lei,HUI Jianrong,et al.Effect and mechanism of moxibustion on survival of triple negative breast cancer transplanted tumor mice[J].,2022,(1):819.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.001]
[7]陈明明,郭 旭,熊乙霓,等.培元固本法治疗乳腺癌化疗后骨髓抑制临床研究[J].陕西中医,2022,(8):1049.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.014]
[8]蔡丽珍,白瑞娜,张 路,等.基于“痰夹瘀血”理论探讨乳腺癌相关淋巴水肿因机治疗[J].陕西中医,2023,(10):1420.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.019]
 CAI Lizhen,BAI Ruina,ZHANG Lu,et al.Based on the theory of “phlegm blended with blood stasis”,to explore the mechanism and treatment of breast cancer related lymphedema[J].,2023,(1):1420.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.019]
[9]宋铁兵,李康乐,马 强,等.土贝母皂苷甲对乳腺癌细胞MCF-7凋亡的影响[J].陕西中医,2023,(11):1514.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.004]
 SONG Tiebing,LI Kangle,MA Qiang,et al.Effect of Tubeimoside I on apoptosis of breast cancer cell MCF-7[J].,2023,(1):1514.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.004]
[10]高 宏,周立江,邢向荣,等.柴胡龙骨牡蛎汤加减治疗乳腺癌研究进展[J].陕西中医,2023,(11):1657.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.040]
 GAO Hong,ZHOU Lijiang,XING Xiangrong,et al.Research progress of Chaihu Longgu Muli decoction in treatment of breast cancer[J].,2023,(1):1657.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.040]

备注/Memo

备注/Memo:
*浙江省名中医专家传承工作室项目(GZS20120031)
更新日期/Last Update: 2020-02-17